✦ LIBER ✦

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial

✍ Scribed by Petchey, William G; Hickman, Ingrid J; Prins, Johannes B; Hawley, Carmel M; Johnson, David W; Isbel, Nicole M

Book ID: 118707318
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 662 KB
Volume: 18
Category: Article
ISSN: 1320-5358
DOI: 10.1111/j.1440-1797.2012.01662.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paricalcitol does not improve glucose me

Paricalcitol does not improve glucose metabolism in patients with stage 3–4 chronic kidney disease

✍ de Boer, Ian H; Sachs, Michael; Hoofnagle, Andrew N; Utzschneider, Kristina M; K 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 633 KB

Fibroblast growth factor 23 and parathyr

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

✍ Bleskestad, Inger H; Bergrem, Harald; Hartmann, Anders; Godang, Kristin; Gøranss 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 216 KB

Efficacy of vitamin E and N-acetylcystei

Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial

✍ Thomas M. Kitzler M.D., Aala Jaberi M.D., Gerald Sendlhofer M.D., Peter Rehak M. 📂 Article 📅 2012 🏛 Springer Vienna 🌐 English ⚖ 863 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

✍ Karthik Ananthasubramaniam; Robert Weiss; Bruce McNutt; Barbara Klauke; Kathleen 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 333 KB

Changes in fibroblast growth factor 23 l

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

✍ Ureña-Torres, Pablo; Prié, Dominique; Keddad, Karim; Preston, Peter; Wilde, Paul 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 220 KB

Zosuquidar, a novel modulator of P-glyco

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

✍ Cripe, L. D.; Uno, H.; Paietta, E. M.; Litzow, M. R.; Ketterling, R. P.; Bennett 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 485 KB